Literature DB >> 22487616

Patients with heart failure in the "intermediate range" of peak oxygen uptake: additive value of heart rate recovery and the minute ventilation/carbon dioxide output slope in predicting mortality.

Luiz Eduardo Ritt1, Ricardo Brandão Oliveira, Jonathan Myers, Ross Arena, Mary Ann Peberdy, Daniel Bensimhon, Paul Chase, Daniel Forman, Marco Guazzi.   

Abstract

PURPOSE: While patients with heart failure who achieve a peak oxygen uptake (peak VO2) of 10 mL·kg(-1)·min(-1) or less are often considered for intensive surveillance or intervention, those achieving 14 mL·kg(-1)·min(-1) or more are generally considered to be at lower risk. Among patients in the "intermediate" range of 10.1 to 13.9 mL·kg(-1)·min(-1), optimally stratifying risk remains a challenge.
METHODS: Patients with heart failure (N = 1167) referred for cardiopulmonary exercise testing were observed for 21 ± 13 months. Patients were classified into 3 groups of peak VO2 (≤10, 10.1-13.9, and ≥14 mL·kg(-1)·min(-1)). The ability of heart rate recovery at 1 minute (HRR1) and the minute ventilation/carbon dioxide output (VE/VCO2) slope to complement peak VO2 in predicting cardiovascular mortality were determined.
RESULTS: Peak VO2, HRR1 (<16 beats per minute), and the VE/VCO2 slope (>34) were independent predictors of mortality (hazard ratio 1.6, 95% CI: 1.2-2.29, P = .006; hazard ratio 1.7, 95% CI: 1.1-2.5, P = .008; and hazard ratio 2.4, 95% CI: 1.6-3.4, P < .001, respectively). Compared with those achieving a peak VO2 ≥ 14 mL·kg(-1)·min(-1), patients within the intermediate range with either an abnormal VE/VCO2 slope or HRR1 had a nearly 2-fold higher risk of cardiac mortality. Those with both an abnormal HRR1 and VE/VCO2 slope had a higher mortality risk than those with a peak VO2 ≤ 10 mL·kg(-1)·min(-1). Survival was not different between those with a peak VO2 ≤ 10 mL·kg(-1)·min(-1) and those in the intermediate range with either an abnormal HRR1 or VE/VCO2 slope.
CONCLUSIONS: HRR1 and the VE/VCO2 slope effectively stratify patients with peak VO2 within the intermediate range into distinct groups at high and low risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22487616      PMCID: PMC7240178          DOI: 10.1097/HCR.0b013e31824f9ddf

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil Prev        ISSN: 1932-7501            Impact factor:   2.081


  33 in total

1.  Influence of high-intensity exercise training on the ventilatory response to exercise in patients with reduced ventricular function.

Authors:  J Myers; G Dziekan; U Goebbels; P Dubach
Journal:  Med Sci Sports Exerc       Date:  1999-07       Impact factor: 5.411

2.  Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure.

Authors:  Ross Arena; Jonathan Myers; Syed Salman Aslam; Elsa B Varughese; Mary Ann Peberdy
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

3.  Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited.

Authors:  J Myers; L Gullestad; R Vagelos; D Do; D Bellin; H Ross; M B Fowler
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

4.  Does peak oxygen pulse complement peak oxygen uptake in risk stratifying patients with heart failure?

Authors:  Ricardo B Oliveira; Jonathan Myers; Claudio Gil S Araújo; Ross Arena; Sandra Mandic; Daniel Bensimhon; Joshua Abella; Paul Chase; Marco Guazzi; Peter Brubaker; Brian Moore; Dalane Kitzman; Mary Ann Peberdy
Journal:  Am J Cardiol       Date:  2009-06-18       Impact factor: 2.778

5.  Predicting peak oxygen consumption during a conservative ramping protocol: implications for the heart failure population.

Authors:  Ross Arena; Reed Humphrey; Mary Ann Peberdy; Michael Madigan
Journal:  J Cardiopulm Rehabil       Date:  2003 May-Jun       Impact factor: 2.081

6.  Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure.

Authors:  O Wada; H Asanoi; K Miyagi; S Ishizaka; T Kameyama; H Seto; S Sasayama
Journal:  Am Heart J       Date:  1993-03       Impact factor: 4.749

7.  Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure.

Authors:  T P Chua; A L Clark; A A Amadi; A J Coats
Journal:  J Am Coll Cardiol       Date:  1996-03-01       Impact factor: 24.094

Review 8.  Exercise intolerance in patients with chronic heart failure.

Authors:  M J Sullivan; M H Hawthorne
Journal:  Prog Cardiovasc Dis       Date:  1995 Jul-Aug       Impact factor: 8.194

9.  Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.

Authors:  D M Mancini; H Eisen; W Kussmaul; R Mull; L H Edmunds; J R Wilson
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

Review 10.  Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure.

Authors:  Lee Ingle
Journal:  Heart Fail Rev       Date:  2007-03-28       Impact factor: 4.654

View more
  5 in total

1.  Additive prognostic value of a cardiopulmonary exercise test score in patients with heart failure and intermediate risk.

Authors:  Luiz E Ritt; Jonathan Myers; Ricardo Stein; Ross Arena; Marco Guazzi; Paul Chase; Daniel Bensimhon; Euan Ashley; Lawrence P Cahalin; Daniel E Forman
Journal:  Int J Cardiol       Date:  2014-10-12       Impact factor: 4.164

2.  Variability in Physical Activity Assessed with Accelerometer Is an Independent Predictor of Mortality in CHF Patients.

Authors:  Michael Melin; Inger Hagerman; Adrian Gonon; Thomas Gustafsson; Eric Rullman
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

3.  Relation between VE/VCO2 slope and maximum phonation time in chronic heart failure patients.

Authors:  Kazuhiro P Izawa; Satoshi Watanabe; Peter H Brubaker; Shinobu Tochimoto; Yasuyuki Hirano; Shinya Matsushima; Tomohiro Suzuki; Koichiro Oka; Takashi Saito; Yutaka Omori; Kengo Suzuki; Naohiko Osada; Kazuto Omiya; Hiroyuki Shimizu; Yoshihiro J Akashi
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 4.  Cardiopulmonary Exercise Test: Background, Applicability and Interpretation.

Authors:  Artur Haddad Herdy; Luiz Eduardo Fonteles Ritt; Ricardo Stein; Claudio Gil Soares de Araújo; Mauricio Milani; Romeu Sérgio Meneghelo; Almir Sérgio Ferraz; Carlos Hossri; Antonio Eduardo Monteiro de Almeida; Miguel Morita Fernandes-Silva; Salvador Manoel Serra
Journal:  Arq Bras Cardiol       Date:  2016-11       Impact factor: 2.000

5.  Clinical usefulness of response profiles to rapidly incremental cardiopulmonary exercise testing.

Authors:  Roberta P Ramos; Maria Clara N Alencar; Erika Treptow; Flávio Arbex; Eloara M V Ferreira; J Alberto Neder
Journal:  Pulm Med       Date:  2013-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.